Algeta to Participate in Upcoming Investor Conferences

Algeta to Participate in Upcoming Investor Conferences 
OSLO, NORWAY -- (Marketwire) -- 02/20/13 --  Algeta ASA (OSE:
ALGETA), a company focused on the development of novel targeted
cancer therapeutics, announces that members of its senior management
team will participate in the following upcoming investor
conferences: 
Citi Global Healthcare Conference 2013 
Date: 25-27 February 2013 
Participants: 
Jeff Albers (President, Algeta US) 
Mike Booth (IR) 
Panel date & time: Tuesday 25 February, 2013, 10:20am EST 
Venue: New York, NY, USA 
Credit Suisse Global Healthcare
One-on-One Conference 
Date: 5-6 March 2013 
Participants: 
Andrew Kay (President & CEO) 
Oystein Soug (CFO) 
Mike Booth (IR) 
Venue: London, UK 
Carnegie Nordic Healthcare Seminar 
Date: 12 March 2013 
Participants: 
Thomas Ramdahl (EVP & CTO) 
Renate Birkeli (IR) 
Presentation date & time: Tuesday 12 March, 2013, 10:05am CET 
Venue: Stockholm, Sweden 
Presentations, where applicable, will be available to download at
www.algeta.com
following these events. 
### 
About Algeta 
Algeta is a company focused on developing novel targeted therapies
for patients
with cancer based on its alpha-pharmaceutical platform.
The Company is headquartered in Oslo, Norway, and has a US
subsidiary, Algeta US, LLC, based in Cambridge, MA performing
commercial marketing operations in the US. Algeta is
listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information
please
visit www.algeta.com. 
Press release: 
http://hugin.info/134655/R/1679224/548304.pdf 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
that: 
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Algeta ASA via Thomson Reuters ONE 
[HUG#1679224] 
For further information, please contact: 
Mike Booth / Renate Birkeli
+47 23 00 67 32
Communications & Corporate Affairs
ir@algeta.com 
Media enquiries:
Mark Swallow
+44 207 638 9571 
Citigate Dewe Rogerson
mark.swallow@citigatedr.co.uk 
Knut Ekern
+47 22 04 82 00 
Gambit Hill & Knowlton
knut.ekern@hkstrategies.com 
Kari Watson
+1 781 235 3060 
MacDougall Biomedical Communications
kwatson@macbiocom.com 
US investor enquiries:
Tricia Swanson
+1 646 378 2953 
The Trout Group
tswanson@troutgroup.com
 
 
Press spacebar to pause and continue. Press esc to stop.